0001104659-23-057260.txt : 20230508
0001104659-23-057260.hdr.sgml : 20230508
20230508171719
ACCESSION NUMBER: 0001104659-23-057260
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230505
FILED AS OF DATE: 20230508
DATE AS OF CHANGE: 20230508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gruia Gabriela
CENTRAL INDEX KEY: 0001860326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 23898929
MAIL ADDRESS:
STREET 1: C/O TSCAN THERAPEUTICS, INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
BUSINESS PHONE: 267-370-5219
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
4
1
tm2314936-2_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-05-05
0
0001781983
Aprea Therapeutics, Inc.
APRE
0001860326
Gruia Gabriela
3805 OLD EASTON ROAD
DOYLESTOWN,
PA
18902
1
0
0
0
0
Stock Options (Right to Buy)
3.8999
2023-05-05
4
A
0
12500
0.00
A
2033-05-05
Common Stock
12500
12500
D
These options shall vest in full on May 5, 2024, subject to the reporting person's continued service through and including the applicable vesting date.
/s/ John Hamill, Attorney-in-fact
2023-05-08